Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Long-Term Debt Repayments (2023 - 2025)

Historic Long-Term Debt Repayments for Perspective Therapeutics (CATX) over the last 5 years, with Q3 2025 value amounting to $13000.0.

  • Perspective Therapeutics' Long-Term Debt Repayments fell 1875.0% to $13000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $51000.0, marking a year-over-year increase of 625.0%. This contributed to the annual value of $48000.0 for FY2024, which is 2941.18% down from last year.
  • According to the latest figures from Q3 2025, Perspective Therapeutics' Long-Term Debt Repayments is $13000.0, which was down 1875.0% from $13000.0 recorded in Q2 2025.
  • Over the past 5 years, Perspective Therapeutics' Long-Term Debt Repayments peaked at $21000.0 during Q3 2023, and registered a low of $8000.0 during Q2 2024.
  • Moreover, its 3-year median value for Long-Term Debt Repayments was $13000.0 (2025), whereas its average is $14090.9.
  • In the last 5 years, Perspective Therapeutics' Long-Term Debt Repayments crashed by 6000.0% in 2024 and then surged by 6250.0% in 2025.
  • Over the past 3 years, Perspective Therapeutics' Long-Term Debt Repayments (Quarter) stood at $12000.0 in 2023, then changed by 0.0% to $12000.0 in 2024, then increased by 8.33% to $13000.0 in 2025.
  • Its Long-Term Debt Repayments stands at $13000.0 for Q3 2025, versus $13000.0 for Q2 2025 and $13000.0 for Q1 2025.